What is Trinity Pharmacy?
Trinity Pharmacy is an emerging entity in the pharmaceutical sector, focused on developing innovative solutions for oral health. The company's core offering, ProDentim, is an advanced oral probiotic supplement. It is formulated with 3.5 billion CFU of specific probiotic strains and natural ingredients, presented in a chewable tablet format. ProDentim aims to cultivate a balanced oral microbiome, addressing common concerns such as persistent bad breath, gum irritation, and tooth sensitivity by promoting long-term oral wellness from within. This product appeals to health-conscious adults aged 30-65 seeking preventative and sustainable oral care alternatives.
How much funding has Trinity Pharmacy raised?
Trinity Pharmacy has raised a total of $82K across 1 funding round:
Debt
$82K
Debt (2021): $82K with participation from PPP
What's next for Trinity Pharmacy?
With the recent substantial expansion capital, Trinity Pharmacy is poised for significant growth. The company is expected to leverage this investment to scale its operations, enhance its product development pipeline, and broaden its market reach. The strategic positioning at a Series B/C stage suggests a focus on market penetration and potentially exploring new therapeutic areas within oral health. Future developments may include clinical validation of ProDentim's efficacy and expansion into new geographical markets.
See full Trinity Pharmacy company page
